ClinicalTrials.Veeva

Menu

Home-based Conservative Care Model for Advanced Kidney Disease

VA Office of Research and Development logo

VA Office of Research and Development

Status

Terminated

Conditions

Chronic Kidney Diseases

Treatments

Other: CC Program

Study type

Interventional

Funder types

Other U.S. Federal agency

Identifiers

NCT06411613
IIR 21-061

Details and patient eligibility

About

This is a randomized pilot study to test the feasibility and acceptability of a novel conservative care (CC) pathway among patients with advanced chronic kidney disease (CKD) who have chosen to forgo initiation of maintenance dialysis, their caregivers and providers.

Full description

This study is a randomized pilot study to test the acceptability and feasibility of a CC pathway, called the Kidney Care at Home Program, with patients with advanced CKD who have chosen to forgo dialysis, their caregivers and providers. The novel CC program will be developed upon an existing home-based multidisciplinary care (MDC) program in the Veterans Affairs (VA) called the Home-Based Primary Care (HBPC) program. HBPC provides for Veterans with multimorbidity and functional limitation with the goal of supporting Veterans' quality of life and mitigating the complications of illness through to the end of life.

The investigators hypothesize that HBPC serves as the ideal starting ground to build the VA's first CC program for Veterans with advanced CKD. The investigators will use implementation science and ethnographic research methods, including field observations, interviews, medical record review, and serial structured surveys on quality of life, symptom burden, care satisfaction and goal concordant care to assess the feasibility and acceptability of the Kidney Care at Home Program (intervention) vs. usual care (control).

Enrollment

2 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Patients:

  • Receives primary +/- nephrology care from VAPS as defined as having at least 1 outpatient primary or nephrology visit in the prior year
  • Advanced CKD as defined as defined as having 2 or more outpatient measures of an eGFR 20 ml/min/1.73m2 separated by 90 or more days
  • Unsure or do not wish to undergo maintenance dialysis
  • Agreement by their VA primary +/- nephrology care provider that patients can participate in the study

Caregivers:

  • Nominated by enrolled patient as a caregiver whom patient agrees to participate in the study

Clinicians:

  • Employed at VAPS
  • Identified by enrolled Veterans as important to their CKD and nominated by the Veteran to be interviewed for the study

Exclusion criteria

Patients:

  • Unable to complete "teach-back" method of informed consent
  • Currently receiving maintenance dialysis
  • Currently enrolled in HBPC Program

Caregivers:

  • Unable to complete "teach-back" method of informed consent
  • If a Veteran withdraws from the study, their caregivers' participation in the study is also terminated at that time

Clinicians:

  • If a Veteran withdraws from the study, their clinicians will no longer be eligible to participate in interviews

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

2 participants in 2 patient groups

CC Program Received Intervention
Experimental group
Description:
The CC Program will be delivered through the existing HBPC infrastructure at VA Puget Sound Health Care System. Each HBPC team is comprised on a lead physician or nurse practitioner, nurse, pharmacist, nutritionist, social worker, psychologist, therapist, and chaplain. At a minimum, subsequent clinical encounters and assessments for each Veteran will be scheduled no less than on a quarterly basis and more often as needed based on the HBPC team's clinical judgment. On a monthly basis, the entire HBPC team will conduct MDC meetings to review each Veteran's medical plan. The Program aims to provide patient-centered, whole-person and team-based care, shared decision-making, active symptom management, advance care planning and end-of-life care.
Treatment:
Other: CC Program
Usual Care
No Intervention group
Description:
Does not receive intervention.

Trial documents
2

Trial contacts and locations

1

Loading...

Central trial contact

Susan Wong, MD MS; Rachel R Smith

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems